Skin Anti-Aging Efficacy of Enzyme-Treated Supercritical Caviar Extract: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

被引:0
|
作者
Na, Gwi Hwan [1 ]
Kim, Sukjin [1 ]
Jung, Hyun Mook [1 ]
Han, Sang Hun [2 ]
Han, Jehee [2 ]
Koo, Yean Kyoung [1 ]
机构
[1] COSMAXBIO, Dept R&I Ctr, Seongnam 13486, South Korea
[2] Almas Caviar, Hwaseong Si 18553, South Korea
关键词
caviar; skin anti-aging; skin wrinkles; skin hydration; skin elasticity; skin whitening; BIOCHEMICAL-COMPOSITION; ACID; FIBROBLASTS; MECHANISMS;
D O I
10.3390/nu16010137
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Oxidative stress in the skin, induced by an unhealthy lifestyle and exposure to UVB radiation, leads to skin aging, including reduced elasticity, formation of wrinkles, moisture loss, and inflammation. In a previous study, we revealed the photoaging effects of enzyme-treated caviar extract (CV) by regulating collagen and hyaluronic acid synthase, melanogenesis, anti-oxidant mechanisms, and inflammation in a UVB irradiation-induced mice model. HPLC and MALDI-TOF were performed to determine the effect of enzyme treatment on the free amino acid contents and peptide molecular weight in supercritical caviar extract. As results of the analysis, CV is mainly composed of low-molecular-weight peptides consisting of leucine, tyrosine, and phenylalanine. Based on our in vitro and in vivo study, we conducted a clinical trial to assess the skin anti-aging efficacy of CV. In this randomized, double-blind, placebo-controlled trial, we measured indicators related to elasticity, wrinkles, and skin hydration at 4 and 8 weeks after consumption of CV. The subjects were categorized into caviar, combination, and placebo groups. After 4 weeks, skin hydration, dermal hydration, and transepidermal water loss all showed significant improvement. Furthermore, after 8 weeks, skin elasticity indexes-R2 (total elasticity), R5 (net elasticity), and R7 (ratio of elastic recovery to total deformation)-exhibited significant increases. Improvement in wrinkle indicators (Rmax, Ra, and Rz) and the whitening indicator melanin pigment was also observed. This is the first report showing that CV has significant skin anti-aging efficacy on human skin. In conclusion, our study suggests that CV can be used as skin anti-aging nutraceuticals through positive effects on skin condition in clinical trials.
引用
下载
收藏
页数:15
相关论文
共 50 条
  • [41] Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
    Rubhana Raqib
    Protim Sarker
    Akhirunnesa Mily
    Nur Haque Alam
    Abu Saleh Mohammed Arifuzzaman
    Rokeya Sultana Rekha
    Jan Andersson
    Gudmundur H Gudmundsson
    Alejandro Cravioto
    Birgitta Agerberth
    BMC Infectious Diseases, 12
  • [42] A randomized, double-blind, placebo-controlled clinical trial of the efficacy of treatment with zinc in children with intractable epilepsy
    Saad, Khaled
    El-Houfey, Amira A.
    El-Hamed, Mohamed A. Abd
    El-Asheer, Osama M.
    Al-Atram, Abdulrahman A.
    Tawfeek, Mostafa S. K.
    FUNCTIONAL NEUROLOGY, 2015, 30 (03) : 181 - 185
  • [43] CLINICAL EFFICACY OF INTRAVENOUS LIDOCAINE FOR THYROIDECTOMY: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
    Oh, J.
    Choi, G. J.
    Kang, H.
    Baek, C.
    Jung, Y. H.
    Ko, J. S.
    ANESTHESIA AND ANALGESIA, 2016, 123 : 573 - 573
  • [44] Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial
    Zhang, Junyan
    Yang, Xiaobin
    Chen, Guangui
    Hu, Jintao
    He, Ying
    Ma, Jinxiang
    Ma, Zhaoen
    Chen, Huifang
    Huang, Yuyi
    Wu, Qiurong
    Liu, Yongping
    Yu, Lu
    Zhang, Hong
    Lai, He
    Zhang, Jianguo
    Zhai, Jinming
    Huang, Minqi
    Zou, Zehong
    Tao, Ailin
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (03) : 346 - 354.e1
  • [45] Efficacy of Weikang Pian in Patients with Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Yan, Lijing
    Yu, Lijin
    Zhao, Linlin
    Wang, Dongsheng
    Qin, Dilan
    Fan, Haiwei
    Cheng, Ling
    Qiu, Musen
    Chen, Xiao
    Zhou, Lu
    Qiu, Juan
    Yao, Jiamei
    Wang, Wenbo
    Qiu, Xinjian
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [46] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [47] Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
    Elmets, Craig A.
    Viner, Jaye L.
    Pentland, Alice P.
    Cantrell, Wendy
    Lin, Hui-Yi
    Bailey, Howard
    Kang, Sewon
    Linden, Kenneth G.
    Heffernan, Michael
    Duvic, Madeleine
    Richmond, Ellen
    Elewski, Boni E.
    Umar, Asad
    Bell, Walter
    Gordon, Gary B.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (24): : 1835 - 1844
  • [48] Marfan Sartan: a randomized, double-blind, placebo-controlled trial
    Milleron, Olivier
    Arnoult, Florence
    Ropers, Jacques
    Aegerter, Philippe
    Detaint, Delphine
    Delorme, Gabriel
    Attias, David
    Tubach, Florence
    Dupuis-Girod, Sophie
    Plauchu, Henry
    Barthelet, Martine
    Sassolas, Francois
    Pangaud, Nicolas
    Naudion, Sophie
    Thomas-Chabaneix, Julie
    Dulac, Yves
    Edouard, Thomas
    Wolf, Jean-Eric
    Faivre, Laurence
    Odent, Sylvie
    Basquin, Adeline
    Habib, Gilbert
    Collignon, Patrick
    Boileau, Catherine
    Jondeau, Guillaume
    EUROPEAN HEART JOURNAL, 2015, 36 (32) : 2160 - U37
  • [49] A double-blind, randomized, placebo-controlled laser trial methodology
    Oussedik, E.
    Saleem, M. D.
    Patel, N. U.
    Feldman, S. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : B11 - B11
  • [50] A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza
    Latte, J
    Taverner, D
    Slobodian, P
    Shakib, S
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (07): : 429 - 432